ClopidogrelisafirstgenerationthienopyridineP2Y12receptorinhibitor.Clopidogrelactsasacardioprotectiveantithrombotic/anticoagulantthatisclinicallyusedtotreatcoronaryarterydiseaseandperipheralvasculardiseaseandalsotopreventmyocardialinfarctionandstroke.
| CasNo. | 120202-66-6 |
|---|---|
| Purity | ≥98% |
| Formula | C16H16ClNO2S•H2SO4 |
| FormulaWt. | 419.90 |
| ChemicalName | (αS)-α-(2-Chlorophenyl-6,7-dihydrothieno[3,2-c]-pyridine-5(4H)-aceticacidmethylester |
| IUPACName | methyl(2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate;sulfuricacid |
| Synonym | Clopidogrelhydrogensulfate;Plavix |
| MeltingPoint | 184°C |
| Solubility | Solubleinwater(84mg/mL),methanol,ethanol(84mg/mL),andDMSO(84mg/mL) |
| Appearance | Whitetooffwhitepowder |
| StoreTemp | Ambient |
|---|---|
| ShipTemp | Ambient |
| MSDS | C4658MSDSPDF |
|---|---|
| InfoSheet | C4658InfoSheetPDF |
ThomasMR,StoreyRF.ImpactofaspirindosingontheeffectsofP2Y12inhibitioninpatientswithacutecoronarysyndromes.JCardiovascTranslRes.2014Feb;7(1):19-28.PMID:24309957.
FerriN,CorsiniA,BellostaS.PharmacologyofthenewP2Y12receptorinhibitors:insightsonpharmacokineticandpharmacodynamicproperties.Drugs.2013Oct;73(15):1681-709.PMID:24114622.
SatoY,MiyashitaA,IwatsuboT,UsuiT.Conclusiveidentificationoftheoxybutynin-hydrolyzingenzymeinhumanliver.DrugMetabDispos.2012May;40(5):902-906.PMID:22293119.
